1,4-Dioxane - re-evaluation of the carcinogenicity and genotoxicity
Health Council of the Netherlands
            Record ID 32016000063
            English
                                                            
                Authors' recommendations:
                The Committee concludes that 1,4-dioxane is presumed to be carcinogenic to man, and recommends classifying the compound in category 1B.
Based on the available data, the Committee recommends classifying 1,4-dioxane as a germ cell mutagen in category 2 (Substances which cause concern for humans owing to the possibility that they may induce heritable mutations in the germ cells of humans). The substance acts via a non-stochastic genotoxic mechanism.
            
                                    
            Details
                        
                Project Status:
                Completed
            
                                                            
                Year Published:
                2015
            
                                    
                URL for published report:
                http://www.gezondheidsraad.nl/sites/default/files/201526_14-dioxane_1.pdf
            
                                                            
                English language abstract:
                An English language summary is available
            
                                    
                Publication Type:
                Not Assigned
            
                                    
                Country:
                Netherlands
            
                                                
                        MeSH Terms
            - Humans
- DNA Damage
- Dioxanes
- Carcinogenicity Tests
Contact
                        
                Organisation Name:
                Health Council of the Netherlands Gezondheidsraad
            
            
                        
                Contact Address:
                Postbus 16052, 2500 BB Den Haag, The Netherlands. Tel: +31 70 340 7520;Fax: +31 70 340 7523
            
                                    
                Contact Name:
                info@gr.nl
            
                                    
                Contact Email:
                info@gr.nl
            
                                    
                Copyright:
                Health Council of the Netherlands
            
                    
                This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.